Month: April 2026

RESTON, Va., April 21, 2026 (GLOBE NEWSWIRE) — Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, announced it will participate in two investor conferences in May:BofA Securities Industrials, Transportation & Airlines Key Leaders Conference, held May 12-14 in New York, NY B. Riley Securities 26th Annual Institutional Investor Conference, held May 20-21 in Marina Del Rey, CAAbout Bowman Consulting Group Ltd.Headquartered in Reston, Virginia, Bowman is a national engineering services firm delivering infrastructure, technology and project management solutions to customers who own, develop and maintain the built environment. With over 2,500 employees in more than 100 locations throughout the United States, Bowman provides extensive planning, engineering, geospatial, construction...

New York, NY, April 21, 2026 (GLOBE NEWSWIRE) — Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on April 17, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Annual Report was due on March 31, 2026, and the Company filed a Notification of Late Filing on Form 12b-25 with the SEC on April 1, 2026. The Notice has no immediate effect on the listing or trading of the...

EDMONTON, Alberta and NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) — TSX, NYSE:STN Stantec, a global leader in sustainable design and engineering, released its 19th annual Sustainability Report, showcasing how sustainability is integrated into the Company’s strategy, growth, and operations. The report details Stantec’s sustainability practices, contributions, and accomplishments for the year ending December 31, 2025. The firm’s 2025 sustainability milestones include:C$5.5 billion in revenue from work that supports the United Nations’ core Sustainable Development Goals, representing 68 percent of total gross revenue. This reflects steady growth since the Company began tracking this work in 2019, when it represented 43 percent of total gross revenue. Global operational carbon neutrality achieved for the fourth consecutive year, with...

HAMPTON, N.H., April 21, 2026 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its first quarter 2026 earnings after the market closes on May 4, 2026. Unitil will host its conference call and webcast on May 5, 2026 at 2:00 p.m. (ET) to review its quarterly results. Related presentation materials will be available before the call on the Company’s Investors page at investors.unitil.com. The conference call will be broadcast live in listen-only mode on the Company’s Investors page at investors.unitil.com. Interested parties may access dial information for the call by registering via web link here. An archive of the webcast will be available for one year on the website at investors.unitil.com. About Unitil Corporation Unitil Corporation provides energy for life by safely and reliably delivering...

MAINZ, Germany, April 21, 2026 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. ET (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update. To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a PIN will be provided. It is recommended to register at least one day in advance. The slide presentation and audio of the webcast will be available via this link. Participants may also access the slides and the webcast of the conference call via the “Events & Presentations” page in the Investor...

KALMAR CORPORATION, PRESS RELEASE, 21 APRIL 2026 AT 13:35 (EEST)  Kalmar’s January–March 2026 interim report to be published on Tuesday, 5 May 2026 Kalmar Corporation will publish its January–March 2026 interim report on 5 May 2026 at approximately 9:00 a.m. EEST. The report will be available at https://www.kalmarglobal.com/investors/ after publication. A live international telephone conference for analysts, investors and media will be arranged on the publishing day at 10:00 a.m. EEST. The event will be held in English. The report will be presented by President & CEO Sami Niiranen and CFO Sakari Ahdekivi. The presentation material will be available at https://www.kalmarglobal.com/investors by the latest 10:00 a.m. EEST. To ask questions, please join the teleconference by registering via the following link: https://events.inderes.com/kalmar/q1-2026/dial-in....

Net sales were $23 million in the second quarter, with gross profit of $7 million and gross margin1 reaching 30.6%, a 12.0 percentage points decline over the Q2 last year Net loss of $7 million compared to $2 million in the same period last year, adjusted EBITDA margin2 of negative 4.4% and adjusted EBITDA2 loss of $1 million for the second quarter Cash flows used by operating activities of $2.4 million and adjusted free cash flow2 was negative $2.0 million for the second quarter, with cash balance and marketable securities3 at $9 million bringing net leverage2 ratio to 10x Advancing a focused strategic reset centered on an enhanced product offering and a disciplined cost structure to drive sustainable, profitable growthMONTREAL, April 21, 2026 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood”, “the Company”, “us”, “we”...

VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada. Expansion Roadmap The Company has published “The Path Forward,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation is now available on the Company’s website at avricore.com/investor-kit. The update outlines Avricore’s progression from NHS-linked pilot programmes...